1. Home
  2. TATT vs IVA Comparison

TATT vs IVA Comparison

Compare TATT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TATT
  • IVA
  • Stock Information
  • Founded
  • TATT 1985
  • IVA 2011
  • Country
  • TATT Israel
  • IVA France
  • Employees
  • TATT N/A
  • IVA N/A
  • Industry
  • TATT Aerospace
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TATT Industrials
  • IVA Health Care
  • Exchange
  • TATT Nasdaq
  • IVA Nasdaq
  • Market Cap
  • TATT 379.0M
  • IVA 359.6M
  • IPO Year
  • TATT 1987
  • IVA 2020
  • Fundamental
  • Price
  • TATT $30.00
  • IVA $3.33
  • Analyst Decision
  • TATT Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • TATT 3
  • IVA 4
  • Target Price
  • TATT $36.00
  • IVA $10.50
  • AVG Volume (30 Days)
  • TATT 206.3K
  • IVA 15.7K
  • Earning Date
  • TATT 08-27-2025
  • IVA 03-26-2025
  • Dividend Yield
  • TATT N/A
  • IVA N/A
  • EPS Growth
  • TATT 81.73
  • IVA N/A
  • EPS
  • TATT 1.14
  • IVA N/A
  • Revenue
  • TATT $160,170,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • TATT $18.62
  • IVA $15.38
  • Revenue Next Year
  • TATT $10.62
  • IVA $24.22
  • P/E Ratio
  • TATT $26.26
  • IVA N/A
  • Revenue Growth
  • TATT 30.57
  • IVA N/A
  • 52 Week Low
  • TATT $12.61
  • IVA $1.53
  • 52 Week High
  • TATT $36.49
  • IVA $4.05
  • Technical
  • Relative Strength Index (RSI)
  • TATT 53.47
  • IVA 51.31
  • Support Level
  • TATT $30.01
  • IVA $3.21
  • Resistance Level
  • TATT $31.86
  • IVA $3.49
  • Average True Range (ATR)
  • TATT 1.35
  • IVA 0.23
  • MACD
  • TATT 0.04
  • IVA 0.03
  • Stochastic Oscillator
  • TATT 51.81
  • IVA 49.23

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: